IRLAB Therapeutics Stock Forward View - Accumulation Distribution
| IRLAB-A Stock | SEK 1.71 0.07 3.93% |
IRLAB Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast IRLAB Therapeutics stock prices and determine the direction of IRLAB Therapeutics AB's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of IRLAB Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the value of RSI of IRLAB Therapeutics' share price is approaching 30. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling IRLAB Therapeutics, making its price go up or down. Momentum 30
Sell Stretched
Oversold | Overbought |
Using IRLAB Therapeutics hype-based prediction, you can estimate the value of IRLAB Therapeutics AB from the perspective of IRLAB Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
IRLAB Therapeutics after-hype prediction price | SEK 1.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
IRLAB |
IRLAB Therapeutics Additional Predictive Modules
Most predictive techniques to examine IRLAB price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IRLAB using various technical indicators. When you analyze IRLAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 9255.32 | 9430.68 |
| Check IRLAB Therapeutics Volatility | Backtest IRLAB Therapeutics | Information Ratio |
IRLAB Therapeutics Trading Date Momentum
| On February 18 2026 IRLAB Therapeutics AB was traded for 1.71 at the closing time. The highest price during the trading period was 1.83 and the lowest recorded bid was listed for 1.70 . The volume for the day was 132.8 K. This history from February 18, 2026 did not cause price change. The trading delta at closing time to the current price is 4.09% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare IRLAB Therapeutics to competition |
Other Forecasting Options for IRLAB Therapeutics
For every potential investor in IRLAB, whether a beginner or expert, IRLAB Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. IRLAB Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in IRLAB. Basic forecasting techniques help filter out the noise by identifying IRLAB Therapeutics' price trends.IRLAB Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IRLAB Therapeutics stock to make a market-neutral strategy. Peer analysis of IRLAB Therapeutics could also be used in its relative valuation, which is a method of valuing IRLAB Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
IRLAB Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how IRLAB Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IRLAB Therapeutics shares will generate the highest return on investment. By undertsting and applying IRLAB Therapeutics stock market strength indicators, traders can identify IRLAB Therapeutics AB entry and exit signals to maximize returns.
IRLAB Therapeutics Risk Indicators
The analysis of IRLAB Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in IRLAB Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting irlab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.37 | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.06 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for IRLAB Therapeutics
The number of cover stories for IRLAB Therapeutics depends on current market conditions and IRLAB Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that IRLAB Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about IRLAB Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
IRLAB Therapeutics Short Properties
IRLAB Therapeutics' future price predictability will typically decrease when IRLAB Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of IRLAB Therapeutics AB often depends not only on the future outlook of the potential IRLAB Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IRLAB Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 401.9 M |
Other Information on Investing in IRLAB Stock
IRLAB Therapeutics financial ratios help investors to determine whether IRLAB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IRLAB with respect to the benefits of owning IRLAB Therapeutics security.